Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
1 |
1001 - Document - Document and Entity Information |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DocumentandEntityInformation |
2 |
Implied Table |
Table |
* |
* |
implied:Table |
3 |
Document - Document and Entity Information [Abstract] |
Abstract |
|
|
kzia:DocumentandEntityInformationAbstract |
4 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
5 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
6 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
7 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
8 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
9 |
Trading Symbol |
Concept (Text/String) |
For Period |
|
dei:TradingSymbol |
10 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
11 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
12 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
13 |
Entity Well-known Seasoned Issuer |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
14 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
15 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
16 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
17 |
1003 - Statement - Consolidated statements of profit or loss and other comprehensive income |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/StatementOfComprehensiveIncomeProfitOrLossByNatureOfExpense-320000 |
18 |
Implied Table |
Table |
* |
* |
implied:Table |
19 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
20 |
Revenue from continuing operations |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromInterest |
21 |
Other income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherRevenue |
22 |
Expenses |
Abstract |
|
|
ifrs-full:ExpenseByNatureAbstract |
23 |
Research and development expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
24 |
General and administrative expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
25 |
Loss on disposal of fixed assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets |
26 |
Fair value losses on financial assets at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss |
27 |
Impairment of financial assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLossOnFinancialAssets |
28 |
Loss on disposal of Cantx, Inc. after income tax expense |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnDisposalsOfInvestments |
29 |
Loss before income tax expense from continuing operations |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
30 |
Income tax benefit |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
31 |
Loss after income tax expense for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
32 |
Other comprehensive income |
Abstract |
|
|
ifrs-full:OtherComprehensiveIncomeAbstract |
33 |
Items that may be reclassified subsequently to profit or loss |
Abstract |
|
|
ifrs-full:ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract |
34 |
Gain (Loss) on the revaluation of available-for-sale financial assets, net of tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax |
35 |
Net exchange difference on translation of financial statements of foreign controlled entities, net of tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation |
36 |
Derecognition of foreign currency reserve relating to Cantx Inc. |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax |
37 |
Other comprehensive income for the year, net of tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
38 |
Total comprehensive income for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
39 |
Loss for the year is attributable to: |
Abstract |
|
|
ifrs-full:ProfitLossAttributableToAbstract |
40 |
Non-controlling interest |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
41 |
Owners of Kazia Therapeutics Limited |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOwnersOfParent |
42 |
Loss after income tax expense for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
43 |
Total comprehensive income for the year is attributable to: |
Abstract |
|
|
ifrs-full:ComprehensiveIncomeAttributableToAbstract |
44 |
Non-controlling interest |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests |
45 |
Owners of Kazia Therapeutics Limited |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent |
46 |
Total comprehensive income for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
47 |
Earnings per share for loss attributable to the owners of Kazia Therapeutics Limited |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
48 |
Basic earnings per share |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
49 |
Diluted earnings per share |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
50 |
1004 - Statement - Consolidated statements of financial position |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/StatementOfFinancialPositionCurrentNonCurrent-210000 |
51 |
Implied Table |
Table |
* |
* |
implied:Table |
52 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
53 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
54 |
Current assets |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
55 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
56 |
Trade and other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
57 |
Income tax refund due |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTaxAssetsCurrent |
58 |
Other |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
59 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
60 |
Non-current assets |
Abstract |
|
|
ifrs-full:NoncurrentAssetsAbstract |
61 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentFinancialAssets |
62 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
63 |
Intangibles |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
64 |
Total non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
65 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
66 |
Liabilities |
Abstract |
|
|
ifrs-full:LiabilitiesAbstract |
67 |
Current liabilities |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
68 |
Trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
69 |
Provisions |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentProvisions |
70 |
Deferred income |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredIncome |
71 |
Contingent consideration |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentConsiderationCurrent |
72 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
73 |
Non-Current liabilities |
Abstract |
|
|
ifrs-full:NoncurrentLiabilitiesAbstract |
74 |
Deferred tax |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
75 |
Provisions |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentProvisions |
76 |
Trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentPayables |
77 |
Contingent consideration |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentConsiderationNoncurrent |
78 |
Total non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
79 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
80 |
Net assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NetAssetsLiabilities |
81 |
Equity |
Abstract |
|
|
ifrs-full:EquityAbstract |
82 |
Contributed equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
83 |
Other contributed equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherEquityInterest |
84 |
Reserves |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherReserves |
85 |
Accumulated losses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
86 |
Equity attributable to the owners of Kazia Therapeutics Limited |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAttributableToOwnersOfParent |
87 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
88 |
1005 - Statement - Statements of changes in equity |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/StatementOfChangesInEquity-610000 |
89 |
Statement of changes in equity [table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
90 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
91 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
92 |
Contributed equity [member] |
Member |
|
|
ifrs-full:IssuedCapitalMember |
93 |
Other Contributed equity [member] |
Member |
|
|
ifrs-full:OtherEquityInterestMember |
94 |
Reserves [member] |
Member |
|
|
ifrs-full:OtherReservesMember |
95 |
Accumulated Losses [member] |
Member |
|
|
ifrs-full:RetainedEarningsMember |
96 |
Non-controlling Interest [member] |
Member |
|
|
ifrs-full:NoncontrollingInterestsMember |
97 |
Statement of changes in equity [line items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
98 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
99 |
Loss after income tax expense for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
100 |
Other comprehensive income for the year, net of tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
101 |
Total comprehensive income for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
102 |
Transactions with owners in their capacity as owners: |
Abstract |
|
|
kzia:TransactionsWithOwnersInTheirCapacityAsOwnersAbstract |
103 |
Share issue costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
104 |
Derecognition of noncontrolling interest |
Concept (Monetary) |
For Period |
Debit |
kzia:DerecognitionOfNonControllingInterest |
105 |
Transfers |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity |
106 |
Derecognition of foreign currency reserves |
Concept (Monetary) |
For Period |
Debit |
kzia:DerecognitionOfForeignCurrencyReserve |
107 |
Cancellation of share capital |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReductionOfIssuedCapital |
108 |
Conversion of convertible note |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
109 |
Employee share-based payment options |
Concept (Monetary) |
For Period |
Credit |
kzia:IncreaseDecreaseThroughEmployeeSharebasedPaymentOptions |
110 |
Share based payments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions |
111 |
Contributions of equity, net of transaction costs |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
112 |
Expired Options |
Concept (Monetary) |
For Period |
Credit |
kzia:IncreaseDecreaseThroughExpireOfOptions |
113 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
114 |
1006 - Statement - Consolidated statements of cash flows |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/StatementOfCashFlowsDirectMethod-510000 |
115 |
Implied Table |
Table |
* |
* |
implied:Table |
116 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
117 |
Cash flows from operating activities |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
118 |
Loss before income tax expense for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
119 |
Adjustments for: |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
120 |
Depreciation and amortisation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense |
121 |
Net loss on disposal of non-current assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets |
122 |
Impairment of property, plant and equipment |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment |
123 |
Share-based payments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
124 |
Foreign exchange differences |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains |
125 |
Shares issued for no consideration |
Concept (Monetary) |
For Period |
Credit |
kzia:SharesIssuedForNoConsideration |
126 |
Gain on legal settlement |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsOnLitigationSettlements |
127 |
Make good credit and rental adjustment |
Concept (Monetary) |
For Period |
Credit |
kzia:AdjustmentsForGainLossOnMakeGoodCreditAndRentalAdjustment |
128 |
Net gain on disposal of CanTx, Inc. |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnDisposalsOfInvestments |
129 |
Interest income accrued |
Concept (Monetary) |
For Period |
Credit |
kzia:AdjustmentsForInterestIncomeAccrued |
130 |
(Gain)/loss on contingent consideration |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ConsiderationPaidReceived |
131 |
Fair value loss on financial assets at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss |
132 |
Impairment of financial assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLossOnFinancialAssets |
133 |
Cash flows from used in operations before changes in working capital |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital |
134 |
Change in operating assets and liabilities: |
Abstract |
|
|
kzia:AdjustmentsForNetChangesInOperatingAssetsAndLiabilitiesAbstract |
135 |
Decrease/(increase) in trade and other receivables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables |
136 |
Increase in income tax refund due |
Concept (Monetary) |
For Period |
Debit |
kzia:AdjustmentsForDecreaseIncreaseInIncomeTaxRefundDue |
137 |
Increase in prepayments |
Concept (Monetary) |
For Period |
Debit |
kzia:AdjustmentsForDecreaseIncreaseInPrepayments |
138 |
Decrease/(increase) in trade and other payables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables |
139 |
(Decrease)/increase in other provisions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForProvisions |
140 |
(Decrease) in deposit paid |
Concept (Monetary) |
For Period |
Debit |
kzia:AdjustmentsForIncreaseDecreaseInDepositPaid |
141 |
Increase in deferred tax liability |
Concept (Monetary) |
For Period |
Debit |
kzia:AdjustmentsForIncreaseDecreaseInDeferredTaxLiabilities |
142 |
Decrease in accrued revenue |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome |
143 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
144 |
Cash flows from investing activities |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
145 |
Payment for purchase of business, net of cash acquired |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities |
146 |
Payments for property, plant and equipment |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
147 |
Payments for intangibles |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities |
148 |
Proceeds from disposal of property, plant and equipment |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
149 |
Proceeds from legal settlement |
Concept (Monetary) |
For Period |
Debit |
kzia:ProceedsFromLegalSettlement |
150 |
Net cash used in investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
151 |
Cash flows from financing activities |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
152 |
Proceeds from issue of shares |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
153 |
Share issue transaction costs |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PaymentsForShareIssueCosts |
154 |
Net cash from financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
155 |
Net (decrease) in cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges |
156 |
Cash and cash equivalents at the beginning of the financial year |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
157 |
Effects of exchange rate changes on cash |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
158 |
Cash and cash equivalents at the end of the financial year |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
159 |
1007 - Disclosure - General information |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfGeneralInformationAboutFinancialStatementsExplanatory |
160 |
Implied Table |
Table |
* |
* |
implied:Table |
161 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
162 |
General information |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory |
163 |
1008 - Disclosure - Significant accounting policies |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
164 |
Implied Table |
Table |
* |
* |
implied:Table |
165 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
166 |
Significant accounting policies |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
167 |
1009 - Disclosure - Critical accounting judgements, estimates and assumptions |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAccountingJudgementsAndEstimatesExplanatory |
168 |
Implied Table |
Table |
* |
* |
implied:Table |
169 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
170 |
Critical accounting judgements, estimates and assumptions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
171 |
1010 - Disclosure - Operating segments |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOperatingSegmentsExplanatory |
172 |
Implied Table |
Table |
* |
* |
implied:Table |
173 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
174 |
Operating segments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOperatingSegmentsExplanatory |
175 |
1011 - Disclosure - Revenue |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRevenueExplanatory |
176 |
Implied Table |
Table |
* |
* |
implied:Table |
177 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
178 |
Revenue |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRevenueExplanatory |
179 |
1012 - Disclosure - Other income |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherOperatingIncomeExplanatory |
180 |
Implied Table |
Table |
* |
* |
implied:Table |
181 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
182 |
Other income |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory |
183 |
1013 - Disclosure - Expenses |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfExpensesExplanatory |
184 |
Implied Table |
Table |
* |
* |
implied:Table |
185 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
186 |
Expenses |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfExpensesExplanatory |
187 |
1014 - Disclosure - Income tax benefit |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIncomeTaxExplanatory |
188 |
Implied Table |
Table |
* |
* |
implied:Table |
189 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
190 |
Income tax benefit |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
191 |
1015 - Disclosure - Current assets - cash and cash equivalents |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCashAndCashEquivalentsExplanatory |
192 |
Implied Table |
Table |
* |
* |
implied:Table |
193 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
194 |
Current assets - cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory |
195 |
1016 - Disclosure - Current assets - trade and other receivables |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherReceivablesExplanatory |
196 |
Implied Table |
Table |
* |
* |
implied:Table |
197 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
198 |
Current assets - trade and other receivables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory |
199 |
1017 - Disclosure - Current assets - income tax refund due |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCurrentAssetsIncomeTaxRefundDueExplanatory |
200 |
Implied Table |
Table |
* |
* |
implied:Table |
201 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
202 |
Current assets - income tax refund due |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfCurrentAssetsIncomeTaxRefundDueExplanatory |
203 |
1018 - Disclosure - Current assets - other |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherCurrentAssetsExplanatory |
204 |
Implied Table |
Table |
* |
* |
implied:Table |
205 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
206 |
Current assets - other |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory |
207 |
1019 - Disclosure - Non-current assets - Financial assets |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAvailableforsaleAssetsExplanatory |
208 |
Implied Table |
Table |
* |
* |
implied:Table |
209 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
210 |
Non-current assets - Financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAvailableforsaleAssetsExplanatory |
211 |
1020 - Disclosure - Non-current assets - property, plant and equipment |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPropertyPlantAndEquipmentExplanatory |
212 |
Implied Table |
Table |
* |
* |
implied:Table |
213 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
214 |
Non-current assets - property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
215 |
1021 - Disclosure - Non-current assets - intangibles |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIntangibleAssetsExplanatory |
216 |
Implied Table |
Table |
* |
* |
implied:Table |
217 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
218 |
Non-current assets - intangibles |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsExplanatory |
219 |
1022 - Disclosure - Trade and other payables |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherPayablesExplanatory |
220 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
221 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
222 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
223 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
224 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
225 |
Trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
226 |
1023 - Disclosure - Provisions |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsExplanatory |
227 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
228 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
229 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
230 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
231 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
232 |
Provisions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfProvisionsExplanatory |
233 |
1024 - Disclosure - Contingent consideration |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfContingentConsiderationLiabilitiesExplanatory |
234 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
235 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
236 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
237 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
238 |
Later than one year [member] |
Member |
|
|
ifrs-full:LaterThanOneYearMember |
239 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
240 |
Contingent consideration |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfContingentConsiderationLiabilitiesExplanatory |
241 |
1025 - Disclosure - Non-current liabilities - deferred tax |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeferredTaxesExplanatory |
242 |
Implied Table |
Table |
* |
* |
implied:Table |
243 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
244 |
Non-current liabilities - deferred tax |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDeferredTaxesExplanatory |
245 |
1026 - Disclosure - Equity - contributed equity |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIssuedCapitalExplanatory |
246 |
Implied Table |
Table |
* |
* |
implied:Table |
247 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
248 |
Equity - contributed equity |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIssuedCapitalExplanatory |
249 |
1027 - Disclosure - Equity - Other contributed equity |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherEquityExplanatory |
250 |
Implied Table |
Table |
* |
* |
implied:Table |
251 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
252 |
Equity - Other contributed equity |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfOtherEquityExplanatory |
253 |
1028 - Disclosure - Equity - reserves |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfReservesAndOtherEquityInterestExplanatory |
254 |
Implied Table |
Table |
* |
* |
implied:Table |
255 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
256 |
Equity - reserves |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory |
257 |
1029 - Disclosure - Equity - dividends |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDividendsExplanatory |
258 |
Implied Table |
Table |
* |
* |
implied:Table |
259 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
260 |
Equity - dividends |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDividendsExplanatory |
261 |
1030 - Disclosure - Financial instruments |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinancialInstrumentsExplanatory |
262 |
Implied Table |
Table |
* |
* |
implied:Table |
263 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
264 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
265 |
1031 - Disclosure - Fair value measurement |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFairValueMeasurementExplanatory |
266 |
Implied Table |
Table |
* |
* |
implied:Table |
267 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
268 |
Fair value measurement |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFairValueMeasurementExplanatory |
269 |
1032 - Disclosure - Key management personnel disclosures |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInformationAboutKeyManagementPersonnelExplanatory |
270 |
Implied Table |
Table |
* |
* |
implied:Table |
271 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
272 |
Key management personnel disclosures |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory |
273 |
1033 - Disclosure - Remuneration of auditors |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAuditorsRemunerationExplanatory |
274 |
Implied Table |
Table |
* |
* |
implied:Table |
275 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
276 |
Remuneration of auditors |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAuditorsRemunerationExplanatory |
277 |
1034 - Disclosure - Contingent liabilities |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfContingentLiabilitiesExplanatory |
278 |
Implied Table |
Table |
* |
* |
implied:Table |
279 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
280 |
Contingent liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfContingentLiabilitiesExplanatory |
281 |
1035 - Disclosure - Commitments |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCommitmentsExplanatory |
282 |
Implied Table |
Table |
* |
* |
implied:Table |
283 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
284 |
Commitments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsExplanatory |
285 |
1036 - Disclosure - Related party transactions |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRelatedPartyExplanatory |
286 |
Implied Table |
Table |
* |
* |
implied:Table |
287 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
288 |
Related party transactions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
289 |
1037 - Disclosure - Parent entity information |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterimFinancialReportingExplanatory |
290 |
Implied Table |
Table |
* |
* |
implied:Table |
291 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
292 |
Parent entity information |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInterimFinancialReportingExplanatory |
293 |
1038 - Disclosure - Business combinations |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfBusinessCombinationsExplanatory |
294 |
Implied Table |
Table |
* |
* |
implied:Table |
295 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
296 |
Business combinations |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBusinessCombinationsExplanatory |
297 |
1039 - Disclosure - Interests in subsidiaries |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterestsInSubsidiariesExplanatory |
298 |
Implied Table |
Table |
* |
* |
implied:Table |
299 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
300 |
Interests in subsidiaries |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory |
301 |
1040 - Disclosure - Deed of cross guarantee |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeedOfCrossGuaranteeExplanatory |
302 |
Implied Table |
Table |
* |
* |
implied:Table |
303 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
304 |
Deed of cross guarantee |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDeedOfCrossGuaranteeExplanatory |
305 |
1041 - Disclosure - Events after the reporting period |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEventsAfterReportingPeriodExplanatory |
306 |
Implied Table |
Table |
* |
* |
implied:Table |
307 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
308 |
Events after the reporting period |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
309 |
1042 - Disclosure - Earnings per share |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEarningsPerShareExplanatory |
310 |
Implied Table |
Table |
* |
* |
implied:Table |
311 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
312 |
Earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
313 |
1043 - Disclosure - Share-based payments |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSharebasedPaymentArrangementsExplanatory |
314 |
Implied Table |
Table |
* |
* |
implied:Table |
315 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
316 |
Share-based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory |
317 |
1044 - Disclosure - Settlement of legal proceedings |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLegalProceedingsExplanatory |
318 |
Implied Table |
Table |
* |
* |
implied:Table |
319 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
320 |
Settlement of legal proceedings |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfLegalProceedingsExplanatory |
321 |
1045 - Disclosure - Significant accounting policies (Policies) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryPolicies |
322 |
Implied Table |
Table |
* |
* |
implied:Table |
323 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
324 |
New or amended Accounting Standards and Interpretations adopted |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DescriptionOfAccountingPolicyForNewRevisedOrAmendingAccountingStandardsAndInterpretationsAdoptedExplanatory |
325 |
Going concern |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGoingConcernExplanatory |
326 |
Basis of preparation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory |
327 |
Parent entity information |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DescriptionOfParentEntityInformationExplanatory |
328 |
Principles of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfConsolidationExplanatory |
329 |
Operating segments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
330 |
Foreign currency translation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
331 |
Revenue recognition |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue |
332 |
Grant Income |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DescriptionOfAccountingPolicyForResearchCostsAndAdvertisingExpenseExplanatory |
333 |
Income tax |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory |
334 |
Current and non-current classification |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DescriptionOfAccountingPolicyForCurrentAndNoncurrentClassificationExplanatory |
335 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents |
336 |
Trade and other receivables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory |
337 |
Investments and other financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory |
338 |
Property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
339 |
Research and development |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory |
340 |
Leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory |
341 |
Intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory |
342 |
Impairment of non-financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory |
343 |
Trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory |
344 |
Compound financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory |
345 |
Provisions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory |
346 |
Employee benefits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory |
347 |
Finance costs |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinanceCostsExplanatory |
348 |
Fair value measurement |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory |
349 |
Issued capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
350 |
Earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
351 |
Goods and Services Tax ('GST') and other similar taxes |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory |
352 |
New Accounting Standards and Interpretations not yet mandatory or early adopted |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DescriptionOfAccountingPolicyForNewAccountingStandardsAndInterpretationsNotYetMandatoryOrEarlyAdoptedExplanatory |
353 |
1046 - Disclosure - Revenue (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRevenueExplanatoryTables |
354 |
Implied Table |
Table |
* |
* |
implied:Table |
355 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
356 |
Summary of revenue |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutRevenueExplanatory |
357 |
1047 - Disclosure - Other income (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherOperatingIncomeExplanatoryTables |
358 |
Implied Table |
Table |
* |
* |
implied:Table |
359 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
360 |
Summary of other income |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutOtherIncomeExplanatory |
361 |
1048 - Disclosure - Expenses (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfExpensesExplanatoryTables |
362 |
Implied Table |
Table |
* |
* |
implied:Table |
363 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
364 |
Summary of expenses |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfExpensesByNatureExplanatory |
365 |
1049 - Disclosure - Income tax benefit (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIncomeTaxExplanatoryTables |
366 |
Implied Table |
Table |
* |
* |
implied:Table |
367 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
368 |
Summary of income tax benefit |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutIncomeTaxExplanatory |
369 |
1050 - Disclosure - Current assets - cash and cash equivalents (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCashAndCashEquivalentsExplanatoryTables |
370 |
Implied Table |
Table |
* |
* |
implied:Table |
371 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
372 |
Summary of cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory |
373 |
1051 - Disclosure - Current assets - trade and other receivables (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherReceivablesExplanatoryTables |
374 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
375 |
Classes of financial assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialAssetsAxis |
376 |
Financial assets, class [member] |
Member |
|
|
ifrs-full:FinancialAssetsMember |
377 |
Trade receivables [member] |
Member |
|
|
ifrs-full:TradeReceivablesMember |
378 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
379 |
Summary of current assets - trade and other receivables |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory |
380 |
Summary of ageing of impaired receivables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:AnalysisOfFinancialAssetsThatAreIndividuallyDeterminedToBeImpaired |
381 |
1052 - Disclosure - Current assets - income tax refund due (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCurrentAssetsIncomeTaxRefundDueExplanatoryTables |
382 |
Implied Table |
Table |
* |
* |
implied:Table |
383 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
384 |
Summary of current assets - income tax refund due |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutCurrentAssetsIncomeTaxRefundDueExplanatory |
385 |
1053 - Disclosure - Current assets - other (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherCurrentAssetsExplanatoryTables |
386 |
Implied Table |
Table |
* |
* |
implied:Table |
387 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
388 |
Summary of current assets - other |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory |
389 |
1054 - Disclosure - Non-current assets - Financial assets (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAvailableforsaleAssetsExplanatoryTables |
390 |
Implied Table |
Table |
* |
* |
implied:Table |
391 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
392 |
Summary of non-current assets - financial assets |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutAvailableforsaleFinancialAssetsExplanatory |
393 |
1055 - Disclosure - Non-current assets - property, plant and equipment (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPropertyPlantAndEquipmentExplanatoryTables |
394 |
Implied Table |
Table |
* |
* |
implied:Table |
395 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
396 |
Summary of non-current assets - property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory |
397 |
Summary of reconciliations of property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfReconciliationOfChangesPropertyPlantAndEquipmentExplanatory |
398 |
1056 - Disclosure - Non-current assets - intangibles (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIntangibleAssetsExplanatoryTables |
399 |
Implied Table |
Table |
* |
* |
implied:Table |
400 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
401 |
Summary of non-current assets - intangibles |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory |
402 |
Summary of reconciliations of intangibles |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillExplanatory |
403 |
1057 - Disclosure - Trade and other payables (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeAndOtherPayablesExplanatoryTables |
404 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
405 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
406 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
407 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
408 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
409 |
Summary of trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory |
410 |
1058 - Disclosure - Provisions (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsExplanatoryTables |
411 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
412 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
413 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
414 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
415 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
416 |
Summary of provisions |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutProvisionsExplanatory |
417 |
1059 - Disclosure - Contingent consideration (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfContingentConsiderationLiabilitiesExplanatoryTables |
418 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
419 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
420 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
421 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
422 |
Later than one year [member] |
Member |
|
|
ifrs-full:LaterThanOneYearMember |
423 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
424 |
Summary of liabilities - contingent consideration |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutContingentConsiderationLiabilitiesExplanatory |
425 |
1060 - Disclosure - Non-current liabilities - deferred tax (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeferredTaxesExplanatoryTables |
426 |
Implied Table |
Table |
* |
* |
implied:Table |
427 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
428 |
Summary of non-current liabilities - deferred tax |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory |
429 |
1061 - Disclosure - Equity - contributed equity (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIssuedCapitalExplanatoryTables |
430 |
Implied Table |
Table |
* |
* |
implied:Table |
431 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
432 |
Summary of equity - contributed equity |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutIssuedCapitalExplanatory |
433 |
Summary of movements in ordinary share capital |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutMovementInOrdinaryShareCapitalExplanatory |
434 |
1062 - Disclosure - Equity - Other contributed equity (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherEquityExplanatoryTables |
435 |
Implied Table |
Table |
* |
* |
implied:Table |
436 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
437 |
Summary of equity - other contributed equity |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutOtherEquityExplanatory |
438 |
1063 - Disclosure - Financial instruments (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinancialInstrumentsExplanatoryTables |
439 |
Statement [table] |
Table |
* |
* |
us-gaap:StatementTable |
440 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
441 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
442 |
Foreign currency risk [member] |
Member |
|
|
ifrs-full:CurrencyRiskMember |
443 |
Statement [line items] |
LineItems |
|
|
us-gaap:StatementLineItems |
444 |
Summary of foreign currency risk |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory |
445 |
Summary of foreign currency risk sensitivity |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk |
446 |
Summary of variable interest rate balances |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateExplanatory |
447 |
Summary of remaining contractual maturities of financial instrument liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities |
448 |
1064 - Disclosure - Fair value measurement (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFairValueMeasurementExplanatoryTables |
449 |
Implied Table |
Table |
* |
* |
implied:Table |
450 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
451 |
Summary of assets and liabilities, measured or disclosed at fair value |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutFairValueMeasurementExplanatory |
452 |
1065 - Disclosure - Key management personnel disclosures (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInformationAboutKeyManagementPersonnelExplanatoryTables |
453 |
Implied Table |
Table |
* |
* |
implied:Table |
454 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
455 |
Summary of compensation made to directors and other members of key management personnel |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutKeyManagementPersonnelExplanatory |
456 |
1066 - Disclosure - Remuneration of auditors (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAuditorsRemunerationExplanatoryTables |
457 |
Implied Table |
Table |
* |
* |
implied:Table |
458 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
459 |
Summary of remuneration of auditors |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfDetailedInformationAboutAuditorsRemunerationExplanatory |
460 |
1067 - Disclosure - Commitments (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCommitmentsExplanatoryTables |
461 |
Implied Table |
Table |
* |
* |
implied:Table |
462 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
463 |
Summary of lease commitments - operating |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory |
464 |
1068 - Disclosure - Related party transactions (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRelatedPartyExplanatoryTables |
465 |
Implied Table |
Table |
* |
* |
implied:Table |
466 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
467 |
Summary of transactions occurred with related parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory |
468 |
1069 - Disclosure - Parent entity information (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterimFinancialReportingExplanatoryTables |
469 |
Implied Table |
Table |
* |
* |
implied:Table |
470 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
471 |
Parent entity financial information |
Concept (Text Block (HTML)) |
For Period |
|
kzia:DisclosureOfParentEntityFinancialInformationExplanatory |
472 |
1070 - Disclosure - Business combinations (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfBusinessCombinationsExplanatoryTables |
473 |
Implied Table |
Table |
* |
* |
implied:Table |
474 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
475 |
Summary of details of acquisition |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory |
476 |
Summary of range of outcomes of contingent consideration |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfContingentLiabilitiesInBusinessCombinationExplanatory |
477 |
1071 - Disclosure - Interests in subsidiaries (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInterestsInSubsidiariesExplanatoryTables |
478 |
Implied Table |
Table |
* |
* |
implied:Table |
479 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
480 |
Summary of interest in subsidiaries |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory |
481 |
1072 - Disclosure - Earnings per share (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEarningsPerShareExplanatoryTables |
482 |
Implied Table |
Table |
* |
* |
implied:Table |
483 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
484 |
Summary of earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:EarningsPerShareExplanatory |
485 |
1073 - Disclosure - Share-based payments (Tables) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSharebasedPaymentArrangementsExplanatoryTables |
486 |
Implied Table |
Table |
* |
* |
implied:Table |
487 |
Text block1 [abstract] |
Abstract |
|
|
kzia:TextBlock1Abstract |
488 |
Summary of share-based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory |
489 |
Summary of valuation for each tranche of options |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory |
490 |
1074 - Disclosure - Significant accounting policies - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation |
491 |
Disclosure of summary of significant accounting policies [table] |
Table |
* |
* |
kzia:DisclosureOfSummaryOfSignificantAccountingPoliciesTable |
492 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
493 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
494 |
Plant and equipment [member] |
Member |
|
|
kzia:PlantAndEquipmentMember |
495 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
496 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
497 |
Patents and intellectual property [member] |
Member |
|
|
ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember |
498 |
Software [member] |
Member |
|
|
ifrs-full:ComputerSoftwareMember |
499 |
Licensing agreement for GDC-0084 [member] |
Member |
|
|
kzia:LicenseAgreementMember |
500 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
501 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
502 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
503 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
504 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
505 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
506 |
Research and development tax incentive program [member] |
Member |
|
|
kzia:ResearchAndDevelopmentTaxIncentiveProgramMember |
507 |
Disclosure of summary of significant accounting policies [line items] |
LineItems |
|
|
kzia:DisclosureOfSummaryOfSignificantAccountingPoliciesLineItems |
508 |
Consolidated loss after income tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
509 |
Net current asset position |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssetsLiabilities |
510 |
Net cash outflows from operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
511 |
Consolidated cash in hand and at bank |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
512 |
Current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
513 |
Excess value of share |
Concept (Monetary) |
For Period |
Credit |
kzia:ExcessValueOfShares |
514 |
Additional tax deduction percentage |
Concept (Percent) |
For Period |
|
kzia:AdditionalTaxDeductionPercentage |
515 |
Earning income |
Concept (Monetary) |
For Period |
Credit |
kzia:InterestIncomeLoss |
516 |
Trade receivables settlement period |
Concept (xbrli:durationItemType) |
For Period |
|
kzia:TradeReceivablesPaymentPeriod |
517 |
Overdue period where trade receivables may be impaired |
Concept (xbrli:durationItemType) |
For Period |
|
kzia:OverduePeriodWhereTradeReceivablesMayBeImpaired |
518 |
Estimated useful life of assets |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrDepreciationRatesPropertyPlantAndEquipment |
519 |
Useful lives of intangible assets |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwill |
520 |
Remaining useful life,licensing agreement |
Concept (Text/String) |
For Period |
|
kzia:IntangibleAssetsWithIndefiniteRemainingUsefulLife |
521 |
Trade and other payables payment period |
Concept (xbrli:durationItemType) |
For Period |
|
kzia:TradePayablesSettlementPeriod |
522 |
1075 - Disclosure - Operating segments - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformation |
523 |
Implied Table |
Table |
* |
* |
implied:Table |
524 |
Disclosure of operating segments [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfOperatingSegmentsAbstract |
525 |
Number of operating segments |
Concept (Integer) |
For Period |
|
kzia:NumberOfOperatingSegments1 |
526 |
Number of major customers |
Concept (Integer) |
For Period |
|
kzia:NumberOfMajorCustomers |
527 |
1076 - Disclosure - Revenue - Summary of revenue (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRevenueSummaryOfRevenue |
528 |
Implied Table |
Table |
* |
* |
implied:Table |
529 |
Revenue [abstract] |
Abstract |
|
|
ifrs-full:RevenueAbstract |
530 |
From continuing operations |
Abstract |
|
|
kzia:ContinuingOperationsAbstract |
531 |
Bank interest |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromInterest |
532 |
Sales revenue |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
533 |
Revenue from continuing operations |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
534 |
1077 - Disclosure - Other income - Summary of other income (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureOtherIncomeSummaryOfOtherIncome |
535 |
Implied Table |
Table |
* |
* |
implied:Table |
536 |
Material income and expense [abstract] |
Abstract |
|
|
ifrs-full:MaterialIncomeAndExpenseAbstract |
537 |
Net foreign exchange gain |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:NetForeignExchangeGain |
538 |
Payroll tax rebate |
Concept (Monetary) |
For Period |
Credit |
kzia:TaxRebatesOnPayroll |
539 |
Subsidies and grants |
Concept (Monetary) |
For Period |
Credit |
kzia:SubsidiesAndGrants |
540 |
Gain on legal settlement |
Concept (Monetary) |
For Period |
Credit |
kzia:GainOnLegalSettlement |
541 |
Reimbursement of expenses |
Concept (Monetary) |
For Period |
Credit |
kzia:ReimbursementOfExpenses |
542 |
Research and development rebate |
Concept (Monetary) |
For Period |
Credit |
kzia:RebateIncomeOnResearchAndDevelopment |
543 |
Gain on revaluation of contingent consideration |
Concept (Monetary) |
For Period |
Credit |
kzia:GainLossOnRevaluationOfContingentConsideration |
544 |
Other income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherIncome |
545 |
1078 - Disclosure - Expenses - Summary of expenses (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureExpensesSummaryOfExpenses |
546 |
Disclosure of expenses by nature [table] |
Table |
* |
* |
kzia:DisclosureOfExpensesByNatureTable |
547 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
548 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
549 |
Leasehold improvements [member] |
Member |
|
|
ifrs-full:LeaseholdImprovementsMember |
550 |
Plant and equipment [member] |
Member |
|
|
kzia:PlantAndEquipmentMember |
551 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
552 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
553 |
Patents and intellectual property [member] |
Member |
|
|
ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember |
554 |
Software [member] |
Member |
|
|
ifrs-full:ComputerSoftwareMember |
555 |
GDC licensing agreement [member] |
Member |
|
|
ifrs-full:LicencesMember |
556 |
Disclosure of expenses by nature [line items] |
LineItems |
|
|
kzia:DisclosureOfExpensesByNatureLineItems |
557 |
Loss before income tax includes the following specific expenses: |
Abstract |
|
|
ifrs-full:ProfitLossAbstract |
558 |
Depreciation |
Concept (Monetary) |
For Period |
|
ifrs-full:DepreciationPropertyPlantAndEquipment |
559 |
Amortisation |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
560 |
Total depreciation and amortisation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationAndAmortisationExpense |
561 |
Impairment of property, plant and equipment |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment |
562 |
Interest and finance charges paid/payable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestExpense |
563 |
Minimum lease payments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MinimumOperatingLeasePayments |
564 |
Defined contribution superannuation expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans |
565 |
Employee benefits expense excluding superannuation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans |
566 |
Revaluation of contingent consideration |
Concept (Monetary) |
For Period |
Debit |
kzia:RevaluationOfContingentConsideratiOnExpense |
567 |
1079 - Disclosure - Income tax benefit - Summary of Income tax benefit (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureIncomeTaxBenefitSummaryOfIncomeTaxBenefit |
568 |
Disclosure of income tax benefits [Table] |
Table |
* |
* |
kzia:DisclosureOfIncomeTaxBenefitsTable |
569 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
570 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
571 |
Australia [member] |
Member |
|
|
country:AU |
572 |
US [member] |
Member |
|
|
country:US |
573 |
Disclosure Of Income Tax Benefit [Line Items] |
LineItems |
|
|
kzia:DisclosureOfIncomeTaxBenefitLineItems |
574 |
Numerical reconciliation of income tax benefit and tax at the statutory rate |
Abstract |
|
|
ifrs-full:ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract |
575 |
Loss before income tax benefit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
576 |
Tax at the statutory tax rate of 27.5% (2017: 27.5%, 2016: 30%) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate |
577 |
Tax effect amounts which are not deductible/(taxable) in calculating taxable income: |
Abstract |
|
|
kzia:TaxEffectAmountsWhichAreNotDeductibleTaxableInCalculatingTaxableIncomeAbstract |
578 |
Impact of foreign tax rate differential |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxEffectOfForeignTaxRates |
579 |
Research and Development claim |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfExpenseResearchAndDevelopmentClaim |
580 |
Capitalised expenses |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfCapitalisedExpenses |
581 |
Employee option plan |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfExpenseEmployeeOptionPlan |
582 |
Gain/loss on revaluation of contingent consideration |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfGainLossOnRevaluationOfContingentConsiderationPayable |
583 |
Other non-deductible expenses |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfOtherNondeductibleExpenses |
584 |
Tax effect amounts which are not deductible/(taxable) in calculating taxable income |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfExpenseNotDeductibleAndTaxableInDeterminingTaxableProfitTaxLoss |
585 |
Prior year tax losses not recognised now recouped |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfPriorYearTaxLossesNotRecognisedNowRecouped |
586 |
Tax losses and timing differences not recognised |
Concept (Monetary) |
For Period |
Debit |
kzia:TaxEffectOfTaxLossesAndTimingDifferencesNotRecognised |
587 |
Income tax benefit |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
588 |
Tax losses not recognised |
Abstract |
|
|
kzia:TaxLossesNotRecognisedAbstract |
589 |
Unused tax losses for which no deferred tax asset has been recognised |
Concept (Monetary) |
As Of |
|
ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised |
590 |
Potential tax benefit |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes |
591 |
1080 - Disclosure - Income tax benefit - Summary of Income tax benefit (Parenthetical) (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureIncomeTaxBenefitSummaryOfIncomeTaxBenefitParenthetical |
592 |
Disclosure of income tax benefits [Table] |
Table |
* |
* |
kzia:DisclosureOfIncomeTaxBenefitsTable |
593 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
594 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
595 |
US [member] |
Member |
|
|
country:US |
596 |
Disclosure Of Income Tax Benefit [Line Items] |
LineItems |
|
|
kzia:DisclosureOfIncomeTaxBenefitLineItems |
597 |
Statutory tax rate |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
598 |
1081 - Disclosure - Current assets - cash and cash equivalents - Summary of cash and cash equivalents (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsCashAndCashEquivalentsSummaryOfCashAndCashEquivalents |
599 |
Implied Table |
Table |
* |
* |
implied:Table |
600 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
601 |
Cash at bank and on hand |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Cash |
602 |
Short-term deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents |
603 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
604 |
1082 - Disclosure - Current assets - trade and other receivables - Summary of current assets - trade and other receivables (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsTradeAndOtherReceivablesSummaryOfCurrentAssetsTradeAndOtherReceivables |
605 |
Disclosure of financial assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialAssetsTable |
606 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
607 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
608 |
Gross carrying amount [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
609 |
Provision for impairment [member] |
Member |
|
|
ifrs-full:AccumulatedImpairmentMember |
610 |
R&D tax rebate receivable [member] |
Member |
|
|
kzia:ResearchAndDevelopmentTaxRebateReceivableMember |
611 |
Deposits held [member] |
Member |
|
|
kzia:DepositsHeldMember |
612 |
Disclosure of financial assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialAssetsLineItems |
613 |
Trade receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTradeReceivables |
614 |
Other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentReceivables |
615 |
Trade and other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
616 |
1083 - Disclosure - Current assets - trade and other receivables - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsTradeAndOtherReceivablesAdditionalInformation |
617 |
Implied Table |
Table |
* |
* |
implied:Table |
618 |
Trade and other receivables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
619 |
Guarantee included in deposits held |
Concept (Monetary) |
As Of |
Debit |
kzia:GuaranteeDepositsAssetsCurrent |
620 |
Recognised a loss in profit or loss in respect of impairment of receivables (excluding 'deposits held') |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables |
621 |
1084 - Disclosure - Current assets - trade and other receivables - Summary of ageing of impaired receivables (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsTradeAndOtherReceivablesSummaryOfAgeingOfImpairedReceivables |
622 |
Disclosure of financial assets that are either past due or impaired [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable |
623 |
Impairment of financial assets [axis] |
Axis |
|
|
ifrs-full:ImpairmentOfFinancialAssetsAxis |
624 |
Entity's total for impairment of financial assets [member] |
Member |
|
|
ifrs-full:EntitysTotalForImpairmentOfFinancialAssetsMember |
625 |
Impaired [member] |
Member |
|
|
ifrs-full:FinancialAssetsImpairedMember |
626 |
Past due status [axis] |
Axis |
|
|
ifrs-full:PastDueStatusAxis |
627 |
Past due status [member] |
Member |
|
|
ifrs-full:PastDueStatusMember |
628 |
Over 6 months [member] |
Member |
|
|
ifrs-full:LaterThanSixMonthsMember |
629 |
Disclosure of financial assets that are either past due or impaired [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems |
630 |
Trade receivables over 6 months overdue |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
631 |
1085 - Disclosure - Current assets - income tax refund due - Summary of current assets - income tax refund due (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsIncomeTaxRefundDueSummaryOfCurrentAssetsIncomeTaxRefundDue |
632 |
Implied Table |
Table |
* |
* |
implied:Table |
633 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
634 |
Income tax refund due |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTaxAssetsCurrent |
635 |
1086 - Disclosure - Current assets - other - Summary of current assets - other (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentAssetsOtherSummaryOfCurrentAssetsOther |
636 |
Implied Table |
Table |
* |
* |
implied:Table |
637 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
638 |
Prepayments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
639 |
1087 - Disclosure - Non-current assets - financial assets - Summary of non-current assets - financial assets (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsFinancialAssetsSummaryOfNoncurrentAssetsFinancialAssets |
640 |
Disclosure of Non-current Financial Assets Available for Sale [Table] |
Table |
* |
* |
kzia:DisclosureOfNoncurrentFinancialAssetsAvailableForSaleTable |
641 |
Categories of financial assets [axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialAssetsAxis |
642 |
Financial assets, category [member] |
Member |
|
|
ifrs-full:FinancialAssetsCategoryMember |
643 |
Listed ordinary shares - available-for-sale [member] |
Member |
|
|
kzia:ListedOrdinarySharesMember |
644 |
Unlisted shares and options - FVTPL [member] |
Member |
|
|
kzia:UnlistedSharesAndOptionsFairValueThroughProfitLossMember |
645 |
Disclosure of non-current financial assets available for sale [line items] |
LineItems |
|
|
kzia:DisclosureOfNoncurrentFinancialAssetsAvailableForSaleLineItems |
646 |
Non-current assets - available for financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentFinancialAssetsAvailableforsale |
647 |
1088 - Disclosure - Non-current assets - property, plant and equipment - Summary of non-current assets - property, plant and equipment (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsPropertyPlantAndEquipmentSummaryOfNoncurrentAssetsPropertyPlantAndEquipment |
648 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
649 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
650 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
651 |
Leasehold improvements [member] |
Member |
|
|
ifrs-full:LeaseholdImprovementsMember |
652 |
Plant and equipment [member] |
Member |
|
|
kzia:PlantAndEquipmentMember |
653 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
654 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
655 |
Gross carrying amount [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
656 |
Accumulated depreciation and amortisation [member] |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
657 |
Disclosure of detailed information about property, plant and equipment [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
658 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
659 |
1089 - Disclosure - Non-current assets - property, plant and equipment - Summary of reconciliations of property, plant and equipment (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsPropertyPlantAndEquipmentSummaryOfReconciliationsOfPropertyPlantAndEquipment |
660 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
661 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
662 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
663 |
Leasehold improvements [member] |
Member |
|
|
ifrs-full:LeaseholdImprovementsMember |
664 |
Plant and equipment [member] |
Member |
|
|
kzia:PlantAndEquipmentMember |
665 |
Disclosure of detailed information about property, plant and equipment [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
666 |
Beginning balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
667 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
668 |
Disposals |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsPropertyPlantAndEquipment |
669 |
Impairment of assets |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment |
670 |
Depreciation expense |
Concept (Monetary) |
For Period |
|
ifrs-full:DepreciationPropertyPlantAndEquipment |
671 |
Ending balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
672 |
1090 - Disclosure - Non-current assets - intangibles - Summary of non-current assets - intangibles (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsIntangiblesSummaryOfNoncurrentAssetsIntangibles |
673 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
674 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
675 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
676 |
Patents and intellectual property [member] |
Member |
|
|
ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember |
677 |
Software [member] |
Member |
|
|
ifrs-full:ComputerSoftwareMember |
678 |
GDC licensing agreement [member] |
Member |
|
|
ifrs-full:LicencesMember |
679 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
680 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
681 |
Gross carrying amount [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
682 |
Accumulated depreciation and amortisation [member] |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
683 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
684 |
Intangibles |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
685 |
1091 - Disclosure - Non-current assets - intangibles - Summary of reconciliations of intangibles (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentAssetsIntangiblesSummaryOfReconciliationsOfIntangibles |
686 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
687 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
688 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
689 |
Software [member] |
Member |
|
|
ifrs-full:ComputerSoftwareMember |
690 |
Patents and intellectual property [member] |
Member |
|
|
ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember |
691 |
GDC licensing agreement [member] |
Member |
|
|
ifrs-full:LicencesMember |
692 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
693 |
Beginning balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
694 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
695 |
Disposals |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsIntangibleAssetsOtherThanGoodwill |
696 |
Additions through business combinations |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
697 |
Amortisation expense |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
698 |
Ending balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
699 |
1092 - Disclosure - Current liabilities - trade and other payables - Summary of current liabilities - trade and other payables (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentLiabilitiesTradeAndOtherPayablesSummaryOfCurrentLiabilitiesTradeAndOtherPayables |
700 |
Implied Table |
Table |
* |
* |
implied:Table |
701 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
702 |
Trade payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
703 |
Accrued payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
704 |
Lease incentive liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLeaseLiabilities |
705 |
Total trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
706 |
1093 - Disclosure - Current liabilities - provisions - Summary of current liabilities - provisions (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentLiabilitiesProvisionsSummaryOfCurrentLiabilitiesProvisions |
707 |
Disclosure of Provisions [Table] |
Table |
* |
* |
kzia:DisclosureOfProvisionsTable |
708 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
709 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
710 |
Employee benefits [member] |
Member |
|
|
kzia:EmployeeBenefitsMember |
711 |
Lease make good [member] |
Member |
|
|
kzia:LeaseMakeGoodMember |
712 |
Disclosure of provisions [line items] |
LineItems |
|
|
kzia:DisclosureOfProvisionsLineItems |
713 |
Current liabilities - provisions |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentProvisions |
714 |
1094 - Disclosure - Current liabilities - Contingent consideration - Summary of current liabilities - Contingent consideration (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCurrentLiabilitiesContingentConsiderationSummaryOfCurrentLiabilitiesContingentConsideration |
715 |
Implied Table |
Table |
* |
* |
implied:Table |
716 |
Disclosure of contingent liabilities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfContingentLiabilitiesAbstract |
717 |
Contingent consideration |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentConsiderationCurrent |
718 |
1095 - Disclosure - Non-current liabilities - deferred tax - Summary of non-current liabilities - deferred tax (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentLiabilitiesDeferredTaxSummaryOfNoncurrentLiabilitiesDeferredTax |
719 |
Implied Table |
Table |
* |
* |
implied:Table |
720 |
Deferred tax assets and liabilities [abstract] |
Abstract |
|
|
ifrs-full:DeferredTaxAssetsAndLiabilitiesAbstract |
721 |
Deferred tax liability associated with Licensing Agreement - Non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
722 |
Amount expected to be settled within 12 months |
Concept (Monetary) |
As Of |
Credit |
kzia:DeferredTaxLiabilitiesCurrent1 |
723 |
Amount expected to be settled after more than 12 months |
Concept (Monetary) |
As Of |
Credit |
kzia:DeferredTaxLiabilitiesNonCurrent1 |
724 |
Deferred tax liability associated with Licensing Agreement - Non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
725 |
1096 - Disclosure - Non-current liabilities - Contingent consideration - Summary of non-current liabilities - Contingent consideration (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureNoncurrentLiabilitiesContingentConsiderationSummaryOfNoncurrentLiabilitiesContingentConsideration |
726 |
Implied Table |
Table |
* |
* |
implied:Table |
727 |
Disclosure of contingent liabilities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfContingentLiabilitiesAbstract |
728 |
Contingent consideration |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentConsiderationNoncurrent |
729 |
1097 - Disclosure - Equity - contributed equity - Summary of equity - contributed equity (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquitySummaryOfEquityContributedEquity |
730 |
Implied Table |
Table |
* |
* |
implied:Table |
731 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
732 |
Ordinary shares - fully paid, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssuedAndFullyPaid |
733 |
Ordinary shares - fully paid |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
734 |
1098 - Disclosure - Equity - contributed equity - Summary of movements in ordinary share capital (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquitySummaryOfMovementsInOrdinaryShareCapital |
735 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
736 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
737 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
738 |
Convertible note conversion [member] |
Member |
|
|
kzia:ConvertibleNoteConversionMember |
739 |
Share issue transaction costs [member] |
Member |
|
|
kzia:ShareIssueTransactionCostsMember |
740 |
Business combinations [axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
741 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
742 |
Acquisition of Glioblast Pty Ltd [member] |
Member |
|
|
kzia:AcquisitionOfGlioblastPtyLtdMember |
743 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
744 |
Shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssuedAndFullyPaid |
745 |
Issue price |
Concept (Share) |
For Period |
|
kzia:SharesIssuedPricePerShare1 |
746 |
Contributed equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
747 |
1099 - Disclosure - Equity - contributed equity - Summary of movements in ordinary share capital (Parenthetical) (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquitySummaryOfMovementsInOrdinaryShareCapitalParenthetical |
748 |
Implied Table |
Table |
* |
* |
implied:Table |
749 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
750 |
Reverse stock split |
Concept (Shares) |
For Period |
|
kzia:ReverseStockSplit |
751 |
Stock value |
Concept (Monetary) |
As Of |
Credit |
kzia:CommonStockValue1 |
752 |
1100 - Disclosure - Equity - contributed equity - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityContributedEquityAdditionalInformation |
753 |
Implied Table |
Table |
* |
* |
implied:Table |
754 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
755 |
Fully paid ordinary shares par value |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
756 |
1101 - Disclosure - Equity - Other contributed equity - Summary of equity -Other contributed equity (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityOtherContributedEquitySummaryOfEquityOtherContributedEquity |
757 |
Implied Table |
Table |
* |
* |
implied:Table |
758 |
Statement of changes in equity [abstract] |
Abstract |
|
|
ifrs-full:StatementOfChangesInEquityAbstract |
759 |
Convertible note - Triaxial |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherEquityInterest |
760 |
1102 - Disclosure - Equity - Other contributed equity - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityOtherContributedEquityAdditionalInformation |
761 |
Implied Table |
Table |
* |
* |
implied:Table |
762 |
Statement of changes in equity [abstract] |
Abstract |
|
|
ifrs-full:StatementOfChangesInEquityAbstract |
763 |
Number of ordinary shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssuedAndFullyPaid |
764 |
Number of ordinary shares available for conversion |
Concept (Shares) |
As Of |
|
kzia:NumberOfOrdinarySharesAvailableForConversion |
765 |
Percentage of capital acquired by third party for early conversion of convertibles notes |
Concept (Percent) |
For Period |
|
kzia:PercentageOfCapitalAcquiredByThirdPartyForEarlyConversionOfConvertiblesNotes |
766 |
Number of convertible note may be converted into ordinary shares |
Concept (Shares) |
For Period |
|
kzia:ConvertibleNoteRepresentsOrdinaryShares |
767 |
1103 - Disclosure - Equity - dividends - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEquityDividendsAdditionalInformation |
768 |
Implied Table |
Table |
* |
* |
implied:Table |
769 |
Statement of changes in equity [abstract] |
Abstract |
|
|
ifrs-full:StatementOfChangesInEquityAbstract |
770 |
Dividends paid |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DividendsPaid |
771 |
Franking credits available |
Concept (Monetary) |
As Of |
Credit |
kzia:FrankingCreditsAvailable |
772 |
1104 - Disclosure - Financial instruments - Summary of foreign currency risk (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfForeignCurrencyRisk |
773 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
774 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
775 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
776 |
Foreign currency risk [member] |
Member |
|
|
ifrs-full:CurrencyRiskMember |
777 |
Currency [Axis] |
Axis |
|
|
us-gaap:CurrencyAxis |
778 |
All Currencies [Domain] |
Member |
|
|
currency:AllCurrenciesDomain |
779 |
US dollars [member] |
Member |
|
|
currency:USD |
780 |
Pound Sterling [member] |
Member |
|
|
currency:GBP |
781 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
782 |
Assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
783 |
Liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
784 |
1105 - Disclosure - Financial instruments - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation |
785 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
786 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
787 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
788 |
Foreign currency risk [member] |
Member |
|
|
ifrs-full:CurrencyRiskMember |
789 |
Interest rate risk [member] |
Member |
|
|
ifrs-full:InterestRateRiskMember |
790 |
Currency [Axis] |
Axis |
|
|
us-gaap:CurrencyAxis |
791 |
All Currencies [Domain] |
Member |
|
|
currency:AllCurrenciesDomain |
792 |
US dollars [member] |
Member |
|
|
currency:USD |
793 |
Euros [member] |
Member |
|
|
currency:EUR |
794 |
Pound Sterling [member] |
Member |
|
|
currency:GBP |
795 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
796 |
Net assets denominated in foreign currencies |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
797 |
Hypothetical percentage change in risk |
Concept (Percent) |
As Of |
|
kzia:RiskExposureAssociatedWithInstrumentsSharingCharacteristicPercentageChangeInRisk |
798 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
799 |
Favourable/adverse effect on profit before tax and equity |
Concept (Monetary) |
As Of |
|
ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic |
800 |
1106 - Disclosure - Financial instruments - Summary of foreign currency risk sensitivity (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfForeignCurrencyRiskSensitivity |
801 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
802 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
803 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
804 |
Foreign currency risk [member] |
Member |
|
|
ifrs-full:CurrencyRiskMember |
805 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
806 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
807 |
Increase in market risk [member] |
Member |
|
|
kzia:IncreaseInMarketRiskMember |
808 |
Effect of increase in market risk on profit (loss) before tax [member] |
Member |
|
|
kzia:EffectOfIncreaseInMarketRiskOnProfitLossBeforeTaxMember |
809 |
Effect of increase in market risk on equity [member] |
Member |
|
|
kzia:EffectOfIncreaseInMarketRiskOnEquityMember |
810 |
Decrease in market risk [member] |
Member |
|
|
kzia:DecreaseInMarketRiskMember |
811 |
Effect of decrease in market risk on equity [member] |
Member |
|
|
kzia:EffectOfDecreaseInMarketRiskOnEquityMember |
812 |
Effect of decrease in market risk on profit (loss) before tax [member] |
Member |
|
|
kzia:EffectOfDecreaseInMarketRiskOnProfitLossBeforeTaxMember |
813 |
Currency [Axis] |
Axis |
|
|
us-gaap:CurrencyAxis |
814 |
All Currencies [Domain] |
Member |
|
|
currency:AllCurrenciesDomain |
815 |
US dollars [member] |
Member |
|
|
currency:USD |
816 |
Pound Sterling [member] |
Member |
|
|
currency:GBP |
817 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
818 |
% change |
Concept (Percent) |
As Of |
|
kzia:RiskExposureAssociatedWithInstrumentsSharingCharacteristicPercentageChangeInRisk |
819 |
Effect on profit before tax/equity |
Concept (Monetary) |
As Of |
|
ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic |
820 |
1107 - Disclosure - Financial instruments - Summary of variable interest rate balances (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfVariableInterestRateBalances |
821 |
Disclosure of financial instruments by type of interest rate [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable |
822 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
823 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
824 |
Interest rate risk [member] |
Member |
|
|
ifrs-full:InterestRateRiskMember |
825 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
826 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
827 |
Variable interest rate [member] |
Member |
|
|
ifrs-full:FloatingInterestRateMember |
828 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
829 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
830 |
Weighted average [member] |
Member |
|
|
ifrs-full:WeightedAverageMember |
831 |
Classes of financial instruments [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialInstrumentsAxis |
832 |
Financial instruments, class [member] |
Member |
|
|
ifrs-full:ClassesOfFinancialInstrumentsMember |
833 |
Cash at bank and in hand [member] |
Member |
|
|
kzia:CashAtBankAndInHandMember |
834 |
Short term deposits [member] |
Member |
|
|
kzia:ShortTermDepositsMember |
835 |
Disclosure of financial instruments by type of interest rate [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems |
836 |
Interest rate |
Concept (Percent) |
For Period |
|
kzia:InterestRate |
837 |
Cash at bank and in hand |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Cash |
838 |
Short term deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents |
839 |
Net exposure to cash flow interest rate risk |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
840 |
1108 - Disclosure - Financial instruments - Summary of remaining contractual maturities of financial instrument liabilities (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfRemainingContractualMaturitiesOfFinancialInstrumentLiabilities |
841 |
Disclosure of maturity analysis for non-derivative financial liabilities [table] |
Table |
* |
* |
ifrs-full:DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable |
842 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
843 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
844 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
845 |
Between 2 and 5 years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember |
846 |
Over 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
847 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
848 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
849 |
Trade payables [member] |
Member |
|
|
kzia:TradePayablesMember |
850 |
Accrued payables [member] |
Member |
|
|
kzia:AccruedPayablesMember |
851 |
Contingent consideration [member] |
Member |
|
|
kzia:ContingentConsiderationMember |
852 |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems |
853 |
Weighted average interest rate |
Concept (Percent) |
As Of |
|
kzia:NonDerivativeFinancialLiabilitiesWeightedAverageInterestRate |
854 |
Trade payables |
Concept (Monetary) |
As Of |
Credit |
kzia:TradePayablesUndiscountedCashFlows |
855 |
Accrued payables |
Concept (Monetary) |
As Of |
Credit |
kzia:AccruedPayablesUndiscountedCashFlows |
856 |
Contingent consideration |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentConsiderationUndiscountedCashFlows |
857 |
Total non-derivatives |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows |
858 |
1109 - Disclosure - Fair value measurement - Summary of assets and liabilities, measured or disclosed at fair value (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementSummaryOfAssetsAndLiabilitiesMeasuredOrDisclosedAtFairValue |
859 |
Disclosure of fair value measurement of assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsTable |
860 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
861 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
862 |
At fair value [member] |
Member |
|
|
ifrs-full:AtFairValueMember |
863 |
Levels of fair value hierarchy [axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
864 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
865 |
Level 1 [member] |
Member |
|
|
ifrs-full:Level1OfFairValueHierarchyMember |
866 |
Level 3 [member] |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
867 |
Categories of financial assets [axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialAssetsAxis |
868 |
Financial assets, category [member] |
Member |
|
|
ifrs-full:FinancialAssetsCategoryMember |
869 |
Listed ordinary shares - available-for-sale [member] |
Member |
|
|
kzia:ListedOrdinarySharesMember |
870 |
Unlisted options [member] |
Member |
|
|
kzia:UnlistedOptionsMember |
871 |
Disclosure of fair value measurement of assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsLineItems |
872 |
Assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentFinancialAssetsAvailableforsale |
873 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
874 |
Contingent consideration |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentConsiderationNoncurrent |
875 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
876 |
1110 - Disclosure - Fair value measurement - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureFairValueMeasurementAdditionalInformation |
877 |
Implied Table |
Table |
* |
* |
implied:Table |
878 |
Disclosure of fair value measurement of assets [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsAbstract |
879 |
Transfers between Level 1 and Level 2 |
Concept (Monetary) |
For Period |
|
ifrs-full:TransfersOutOfLevel1IntoLevel2OfFairValueHierarchyAssets |
880 |
Transfers between Level 2 and Level 1 |
Concept (Monetary) |
For Period |
|
ifrs-full:TransfersOutOfLevel2IntoLevel1OfFairValueHierarchyAssets |
881 |
Transfers into Level 3 |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TransfersIntoLevel3OfFairValueHierarchyAssets |
882 |
Transfers out of Level 3 |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets |
883 |
1111 - Disclosure - Key management personnel disclosures - Summary of compensation made to directors and other members of key management personnel (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureKeyManagementPersonnelDisclosuresSummaryOfCompensationMadeToDirectorsAndOtherMembersOfKeyManagementPersonnel |
884 |
Implied Table |
Table |
* |
* |
implied:Table |
885 |
Related party transactions [abstract] |
Abstract |
|
|
ifrs-full:RelatedPartyTransactionsAbstract |
886 |
Short-term employee benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
887 |
Post-employment benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits |
888 |
Long-term benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits |
889 |
Termination benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationTerminationBenefits |
890 |
Share-based payments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
891 |
Key management personnel compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensation |
892 |
1112 - Disclosure - Remuneration of auditors - Summary of remuneration of auditors (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRemunerationOfAuditorsSummaryOfRemunerationOfAuditors |
893 |
Implied Table |
Table |
* |
* |
implied:Table |
894 |
Auditor's remuneration [abstract] |
Abstract |
|
|
ifrs-full:AuditorsRemunerationAbstract |
895 |
Audit or review of the financial statements |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemunerationForAuditServices |
896 |
F3 consent |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemunerationForOtherServices |
897 |
Tax compliance services |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemunerationForTaxServices |
898 |
Auditors remuneration |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemuneration |
899 |
1113 - Disclosure - Contingent liabilities - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureContingentLiabilitiesAdditionalInformation |
900 |
Implied Table |
Table |
* |
* |
implied:Table |
901 |
Disclosure of contingent liabilities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfContingentLiabilitiesAbstract |
902 |
Guarantee provided to confirm its commitment to the ongoing enforcement process |
Concept (Monetary) |
As Of |
Debit |
kzia:GuaranteeDepositsAssetsCurrent |
903 |
1114 - Disclosure - Commitments - Summary of lease commitments - operating (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseCommitmentsOperating |
904 |
Disclosure of finance lease and operating lease by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable |
905 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
906 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
907 |
1 year or less [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
908 |
One to five years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember |
909 |
Disclosure of finance lease and operating lease by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems |
910 |
Lease commitments - operating |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease |
911 |
1115 - Disclosure - Commitments - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureCommitmentsAdditionalInformation |
912 |
Implied Table |
Table |
* |
* |
implied:Table |
913 |
Disclosure of finance lease and operating lease by lessee [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeAbstract |
914 |
Leases of premises and plant and equipment under non-cancellable operating leases expiration period |
Concept (xbrli:durationItemType) |
For Period |
|
kzia:OperatingLeaseCommitmentsExpiryTerm |
915 |
1116 - Disclosure - Related party transactions - Summary of transactions occurred with related parties (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRelatedPartyTransactionsSummaryOfTransactionsOccurredWithRelatedParties |
916 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
917 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
918 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
919 |
Watkins Coffey Martin [member] |
Member |
|
|
kzia:WatkinsCoffeyMartinMember |
920 |
Prue Kelly [member] |
Member |
|
|
kzia:PrueKellyMember |
921 |
Iain Ross [member] |
Member |
|
|
kzia:IainRossMember |
922 |
Kumara Inc [member] |
Member |
|
|
kzia:KumaraIncMember |
923 |
John O'Connor [member] |
Member |
|
|
kzia:JohnOConnorMember |
924 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
925 |
Accounting fees paid |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherFeeAndCommissionExpense |
926 |
Salary paid |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:WagesAndSalaries |
927 |
Director's fees, Consultancy fees for executive duties |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProfessionalFeesExpense |
928 |
1117 - Disclosure - Related party transactions - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation |
929 |
Implied Table |
Table |
* |
* |
implied:Table |
930 |
Related party transactions [abstract] |
Abstract |
|
|
ifrs-full:RelatedPartyTransactionsAbstract |
931 |
Other transactions with related parties |
Concept (Monetary) |
For Period |
Credit |
kzia:OtherTransactionsWithRelatedParty |
932 |
Trade receivables from related parties |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:AmountsReceivableRelatedPartyTransactions |
933 |
Trade payables to related parties |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AmountsPayableRelatedPartyTransactions |
934 |
Loan to related parties |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions |
935 |
Loan from related parties |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OutstandingCommitmentsMadeByEntityRelatedPartyTransactions |
936 |
1118 - Disclosure - Parent entity information - Statement of profit or loss and other comprehensive income (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureParentEntityInformationStatementOfProfitOrLossAndOtherComprehensiveIncome |
937 |
Disclosure Of Parent Entity Information [Table] |
Table |
* |
* |
kzia:DisclosureOfParentEntityInformationTable |
938 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
939 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
940 |
Parent [member] |
Member |
|
|
ifrs-full:ParentMember |
941 |
Disclosure of parent entity information [line items] |
LineItems |
|
|
kzia:DisclosureOfParentEntityInformationLineItems |
942 |
Loss after income tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
943 |
Total comprehensive income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
944 |
1119 - Disclosure - Parent entity information - Statement of financial position (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureParentEntityInformationStatementOfFinancialPosition |
945 |
Disclosure Of Parent Entity Information [Table] |
Table |
* |
* |
kzia:DisclosureOfParentEntityInformationTable |
946 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
947 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
948 |
Parent [member] |
Member |
|
|
ifrs-full:ParentMember |
949 |
Disclosure of parent entity information [line items] |
LineItems |
|
|
kzia:DisclosureOfParentEntityInformationLineItems |
950 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
951 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
952 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
953 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
954 |
Equity |
Abstract |
|
|
ifrs-full:EquityAbstract |
955 |
Contributed equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
956 |
Other contributed equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherEquityInterest |
957 |
Reserves |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherReserves |
958 |
Accumulated losses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
959 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
960 |
1120 - Disclosure - Parent entity information - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureParentEntityInformationAdditionalInformation |
961 |
Disclosure Of Parent Entity Information [Table] |
Table |
* |
* |
kzia:DisclosureOfParentEntityInformationTable |
962 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
963 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
964 |
Parent [member] |
Member |
|
|
ifrs-full:ParentMember |
965 |
Disclosure of parent entity information [line items] |
LineItems |
|
|
kzia:DisclosureOfParentEntityInformationLineItems |
966 |
Share based payments reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfSharebasedPayments |
967 |
Available for sale reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssets |
968 |
Contingent liabilities |
Concept (Monetary) |
As Of |
Credit |
kzia:ContingentLiabilities |
969 |
Capital commitments for property, plant and equipment |
Concept (Monetary) |
As Of |
Credit |
kzia:CapitalCommitmentsPropertyPlantAndEquipment |
970 |
1121 - Disclosure - Business combinations - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformation |
971 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
972 |
Business combinations [axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
973 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
974 |
Glioblast Pty Ltd [member] |
Member |
|
|
kzia:GlioblastPtyLtdMember |
975 |
Genentech agreement [member] |
Member |
|
|
kzia:GenentechAgreementMember |
976 |
Disclosure of detailed information about business combination [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfBusinessCombinationsLineItems |
977 |
Percentage acquired of the issued shares |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfVotingEquityInterestsAcquired |
978 |
Acquisition-related costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination |
979 |
Goodwill arising from business combination |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
980 |
Revenue of acquiree from the date of acquisition |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueOfAcquiree |
981 |
Profit of acquiree from the date of acquisition |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossOfAcquiree |
982 |
Group's revenue had the acquisition occurred on 1 July 2016 |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueOfCombinedEntity |
983 |
Number of contingent milestone payments |
Concept (Integer) |
For Period |
|
kzia:NumberOfContingentMilestonePayments |
984 |
Milestone payment discount rate |
Concept (Percent) |
For Period |
|
kzia:MilestonePaymentDiscountRate |
985 |
1122 - Disclosure - Business combinations - Summary of details of acquisition (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureBusinessCombinationsSummaryOfDetailsOfAcquisition |
986 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
987 |
Business combinations [axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
988 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
989 |
Glioblast Pty Ltd [member] |
Member |
|
|
kzia:GlioblastPtyLtdMember |
990 |
Disclosure of detailed information about business combination [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfBusinessCombinationsLineItems |
991 |
Intellectual property |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate |
992 |
Deferred tax liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate |
993 |
Net assets acquired |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed |
994 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
995 |
Acquisition-date fair value of the total consideration transferred |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred |
996 |
Cash paid or payable to vendor |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CashTransferred |
997 |
Less: shares issued by company as part of consideration |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityInterestsOfAcquirer |
998 |
Contingent consideration |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate |
999 |
Total |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred |
1000 |
1123 - Disclosure - Business combinations - Summary of range of outcomes of contingent consideration (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureBusinessCombinationsSummaryOfRangeOfOutcomesOfContingentConsideration |
1001 |
Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationTable |
1002 |
Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis] |
Axis |
|
|
ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis |
1003 |
Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [member] |
Member |
|
|
ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember |
1004 |
Milestone 1 [member] |
Member |
|
|
kzia:MilestonesOneMember |
1005 |
Milestone 2 [member] |
Member |
|
|
kzia:MilestonesTwoMember |
1006 |
Milestone 3 [member] |
Member |
|
|
kzia:MilestonesThreeMember |
1007 |
Milestone 4 [member] |
Member |
|
|
kzia:MilestonesFourMember |
1008 |
Milestone 5 [member] |
Member |
|
|
kzia:MilestonesFiveMember |
1009 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
1010 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
1011 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
1012 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
1013 |
Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationLineItems |
1014 |
Contingent consideration |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate |
1015 |
1124 - Disclosure - Interests in subsidiaries - Summary of interest in subsidiaries (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureInterestsInSubsidiariesSummaryOfInterestInSubsidiaries |
1016 |
Disclosure of subsidiaries [table] |
Table |
* |
* |
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesTable |
1017 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
1018 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
1019 |
Kazia Laboratories Pty Ltd [member] |
Member |
|
|
kzia:KaziaLaboratoriesPtyLtdMember |
1020 |
Kazia Research Pty Ltd [member] |
Member |
|
|
kzia:KaziaResearchPtyLtdMember |
1021 |
Kazia Therapeutics Inc [member] |
Member |
|
|
kzia:KaziaTherapeuticsIncMember |
1022 |
Glioblast Pty Ltd [member] |
Member |
|
|
kzia:GlioblastPtyLtdMember |
1023 |
Disclosure of subsidiaries [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
1024 |
Principal place of business |
Concept (Text/String) |
For Period |
|
ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary |
1025 |
Country of incorporation |
Concept (Text/String) |
For Period |
|
ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary |
1026 |
Ownership interest |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
1027 |
1125 - Disclosure - Deed of cross guarantee - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureDeedOfCrossGuaranteeAdditionalInformation |
1028 |
Disclosure of deed of cross guarantee [table] |
Table |
* |
* |
kzia:DisclosureOfDeedOfCrossGuaranteeTable |
1029 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
1030 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
1031 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
1032 |
Disclosure of deed of cross guarantee [line items] |
LineItems |
|
|
kzia:DisclosureOfDeedOfCrossGuaranteeLineItems |
1033 |
General and Administrative expenses, difference amount of closed group to that off consolidated entity |
Concept (Monetary) |
For Period |
Debit |
kzia:GeneralAndAdministrativeExpensesDifferenceAmountOfClosedGroupAndConsolidatedEntity |
1034 |
Income (loss) before tax, difference amount of closed group to that off consolidated entity |
Concept (Monetary) |
For Period |
Credit |
kzia:IncomeLossBeforeTaxDifferenceAmountOfClosedGroupAndConsolidatedEntity |
1035 |
Income (loss) after tax, difference amount of closed group to that off consolidated entity |
Concept (Monetary) |
For Period |
Credit |
kzia:IncomeLossAfterTaxDifferenceAmountOfClosedGroupAndConsolidatedEntity |
1036 |
Assets of closed group differ from consolidated entity |
Concept (Monetary) |
For Period |
Debit |
kzia:AssetsDifferenceAmountOfClosedGroupFromConsolidatedEntity |
1037 |
Liabilities of closed group differ from consolidated entity |
Concept (Monetary) |
For Period |
Credit |
kzia:LiabilitiesDifferenceAmountOfClosedGroupFromConsolidatedEntity |
1038 |
Net assets of closed group differ from consolidated entity |
Concept (Monetary) |
For Period |
Debit |
kzia:NetAssetsOfClosedGroupDifferFromConsolidatedEntity |
1039 |
1126 - Disclosure - Events after the reporting period - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEventsAfterTheReportingPeriodAdditionalInformation |
1040 |
Disclosure of non-adjusting events after reporting period [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable |
1041 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
1042 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
1043 |
Anti tropomyosin program [member] |
Member |
|
|
kzia:AntiTropomyosinProgramMember |
1044 |
Subsequent Event [Member] |
Member |
|
|
us-gaap:SubsequentEventMember |
1045 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
1046 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
1047 |
Share purchase plan [Member] |
Member |
|
|
kzia:SharePurchasePlanMember |
1048 |
Legal Entity [Axis] |
Axis |
|
|
dei:LegalEntityAxis |
1049 |
Entity [Domain] |
Member |
|
|
dei:EntityDomain |
1050 |
TroBio Therapeutics Proprietary Limited [Member] |
Member |
|
|
kzia:TrobioTherapeuticsProprietaryLimitedMember |
1051 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
1052 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
1053 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
1054 |
Disclosure of non-adjusting events after reporting period [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems |
1055 |
Equity interest, percentage |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInAssociate |
1056 |
Share placement amount |
Concept (Monetary) |
For Period |
Credit |
kzia:SharePlacementAmount |
1057 |
Share placement eligibility ownership capacity amount |
Concept (Monetary) |
For Period |
Credit |
kzia:SharePlacementEligibilityOwnershipCapacityAmount |
1058 |
Share purchase plan maturity date |
Concept (Date) |
For Period |
|
kzia:SharePurchasePlanMaturityDate |
1059 |
1127 - Disclosure - Earnings per share - Summary of earnings per share (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEarningsPerShareSummaryOfEarningsPerShare |
1060 |
Implied Table |
Table |
* |
* |
implied:Table |
1061 |
Earnings per share [abstract] |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
1062 |
Loss after income tax attributable to the owners of Kazia Therapeutics Limited |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
1063 |
Non-controlling interest |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
1064 |
Loss after income tax attributable to the owners of Kazia Therapeutics Limited |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOwnersOfParent |
1065 |
Weighted average number of ordinary shares used in calculating basic earnings per share |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
1066 |
Weighted average number of ordinary shares used in calculating diluted earnings per share |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
1067 |
Basic earnings per share |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
1068 |
Diluted earnings per share |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
1069 |
1128 - Disclosure - Earnings per share - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureEarningsPerShareAdditionalInformation |
1070 |
Earnings per share [table] |
Table |
* |
* |
ifrs-full:EarningsPerShareTable |
1071 |
Classes of financial assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialAssetsAxis |
1072 |
Financial assets, class [member] |
Member |
|
|
ifrs-full:FinancialAssetsMember |
1073 |
Unlisted options [member] |
Member |
|
|
kzia:UnlistedOptionsMember |
1074 |
Listed options [member] |
Member |
|
|
kzia:ListedOptionMember |
1075 |
Earnings per share [line items] |
LineItems |
|
|
ifrs-full:EarningsPerShareLineItems |
1076 |
Number of unlisted convertible notes |
Concept (Shares) |
As Of |
|
kzia:NumberOfOrdinarySharesAvailableForConversion |
1077 |
Face value of convertible notes |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherEquityInterest |
1078 |
Number of options that have been excluded from the calculations as they were antidilutive |
Concept (Shares) |
For Period |
|
kzia:NumberOfAntidilutiveShareOptionsExcludedFromCalculationOfEarningsPerShare |
1079 |
1129 - Disclosure - Share-based payments - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSharebasedPaymentsAdditionalInformation |
1080 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
1081 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
1082 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
1083 |
Tranche 9 [member] |
Member |
|
|
kzia:TrancheNineMember |
1084 |
Tranche 10 [member] |
Member |
|
|
kzia:TrancheTenMember |
1085 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
1086 |
Employee remuneration expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
1087 |
Options expired |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement |
1088 |
Weighted average remaining contractual life of outstanding share options |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
1089 |
Number of options issued to employees |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
1090 |
Options vesting period |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
1091 |
Options expiry period |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement |
1092 |
1130 - Disclosure - Share-based payments - Summary of share-based payments (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSharebasedPaymentsSummaryOfSharebasedPayments |
1093 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
1094 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
1095 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
1096 |
Tranche 1 [member] |
Member |
|
|
kzia:TrancheOneMember |
1097 |
Tranche 2 [member] |
Member |
|
|
kzia:TrancheTwoMember |
1098 |
Tranche 3 [member] |
Member |
|
|
kzia:TrancheThreeMember |
1099 |
Tranche 4 [member] |
Member |
|
|
kzia:TrancheFourMember |
1100 |
Tranche 5 [member] |
Member |
|
|
kzia:TrancheFiveMember |
1101 |
Tranche 6 [member] |
Member |
|
|
kzia:TrancheSixMember |
1102 |
Tranche 7 [member] |
Member |
|
|
kzia:TrancheSevenMember |
1103 |
Tranche 8 [member] |
Member |
|
|
kzia:TrancheEightMember |
1104 |
Tranche 9 [member] |
Member |
|
|
kzia:TrancheNineMember |
1105 |
Tranche 10 [member] |
Member |
|
|
kzia:TrancheTenMember |
1106 |
Tranche 11 [member] |
Member |
|
|
kzia:TrancheElevenMember |
1107 |
Tranche 12 [member] |
Member |
|
|
kzia:TrancheTwelveMember |
1108 |
Tranche 13 [member] |
Member |
|
|
kzia:TrancheThirteenMember |
1109 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
1110 |
Grant date |
Concept (Text/String) |
For Period |
|
ifrs-full:DateOfGrantOfSharebasedPaymentArrangement |
1111 |
Expiry date |
Concept (Date) |
For Period |
|
kzia:ShareBasedPaymentArrangementOptionsExpiryDate |
1112 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:ExercisePriceShareOptionsGranted |
1113 |
Balance at the start of the year, share options |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
1114 |
Granted, share options |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
1115 |
Share Consolidation, share options |
Concept (Shares) |
For Period |
|
kzia:NumberOfShareOptionsConsolidated |
1116 |
Exercised, share options |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
1117 |
Forfeited on cessation of employment, share options |
Concept (Decimal) |
For Period |
|
kzia:NumberOfShareOptionsForfeitedOrExpiredInSharebasedPaymentArrangement |
1118 |
Balance at the end of the year, share options |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
1119 |
Balance at the start of the year, Weighted average exercise price |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
1120 |
Granted, Weighted average exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
1121 |
Exercised, Weighted average exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
1122 |
Forfeited on cessation of employment, Weighted average exercise price |
Concept (Monetary) |
For Period |
|
kzia:WeightedAverageExercisePriceOfShareOptionsForfeitedOrExpiredInSharebasedPaymentArrangement |
1123 |
Balance at the end of the year, Weighted average exercise price |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
1124 |
1131 - Disclosure - Share-based payments - Summary of valuation for each tranche of options (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSharebasedPaymentsSummaryOfValuationForEachTrancheOfOptions |
1125 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
1126 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
1127 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
1128 |
Tranche 1 [member] |
Member |
|
|
kzia:TrancheOneMember |
1129 |
Tranche 2 [member] |
Member |
|
|
kzia:TrancheTwoMember |
1130 |
Tranche 3 [member] |
Member |
|
|
kzia:TrancheThreeMember |
1131 |
Tranche 4 [member] |
Member |
|
|
kzia:TrancheFourMember |
1132 |
Tranche 5 [member] |
Member |
|
|
kzia:TrancheFiveMember |
1133 |
Tranche 6 [member] |
Member |
|
|
kzia:TrancheSixMember |
1134 |
Tranche 7 [member] |
Member |
|
|
kzia:TrancheSevenMember |
1135 |
Tranche 8 [member] |
Member |
|
|
kzia:TrancheEightMember |
1136 |
Tranche 9 [member] |
Member |
|
|
kzia:TrancheNineMember |
1137 |
Tranche 10 [member] |
Member |
|
|
kzia:TrancheTenMember |
1138 |
Tranche 11 [member] |
Member |
|
|
kzia:TrancheElevenMember |
1139 |
Tranche 12 [member] |
Member |
|
|
kzia:TrancheTwelveMember |
1140 |
Tranche 13 [member] |
Member |
|
|
kzia:TrancheThirteenMember |
1141 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
1142 |
Grant date |
Concept (Text/String) |
For Period |
|
ifrs-full:DateOfGrantOfSharebasedPaymentArrangement |
1143 |
Expiry date |
Concept (Date) |
For Period |
|
kzia:ShareBasedPaymentArrangementOptionsExpiryDate |
1144 |
Share price at Grant Date |
Concept (Share) |
For Period |
|
kzia:SharePricePerShare |
1145 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:ExercisePriceShareOptionsGranted |
1146 |
Volatility (%) |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted |
1147 |
Remaining Option Life |
Concept (Decimal) |
For Period |
|
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted |
1148 |
Risk free Rate |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted |
1149 |
Fair value per option |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
1150 |
1132 - Disclosure - Settlement of legal proceedings - Additional Information (Detail) |
Network |
* |
* |
http://www.kaziatherapeutics.com/taxonomy/role/DisclosureSettlementOfLegalProceedingsAdditionalInformation |
1151 |
Disclosure Of Legal Proceedings [Table] |
Table |
* |
* |
kzia:DisclosureOfLegalProceedingsTable |
1152 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
1153 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
1154 |
Noxopharm Limited [member] |
Member |
|
|
kzia:NoxopharmLimitedMember |
1155 |
Disclosure of Legal Proceedings [line items] |
LineItems |
|
|
kzia:DisclosureOfLegalProceedingsLineItems |
1156 |
Shares held in escrow |
Concept (Shares) |
As Of |
|
kzia:SharesHeldInEscrow |
1157 |
Settlement of legal proceedings |
Concept (Monetary) |
For Period |
Credit |
kzia:ValueOfSettlementOfLegalProceedings |
1158 |
Number of unlisted options |
Concept (Decimal) |
As Of |
|
kzia:NumberOfUnlistedOptions |
1159 |
Excise price of unlisted options |
Concept (Share) |
For Period |
|
kzia:UnlistedOptionsExercisePrice |
1160 |
Extinguishment of convertible notes |
Concept (Monetary) |
For Period |
Debit |
kzia:ExtinguishmentOfConvertibleNotes |
1161 |
Cash payments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AmountsPayableRelatedPartyTransactions |
1162 |
Other income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherIncome |
1163 |
Change in equity |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ChangesInEquity |